SEMA3A and amyotrophic lateral sclerosis: Furthermore, blockade of Sema3A signaling by anti-NRP1 antibody (21) or inhibition of CRMP1 phosphorylation (23) mitigates NMJ damage and restores muscle strength in the G93A-SOD1 mouse model of ALS.